All of us at USDM are looking forward to working with stakeholders to help their organizations implement UDI in a way that helps them realize all the benefits of UDI.
SANTA BARBARA, CALIFORNIA (PRWEB) October 28, 2014
USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, is pleased to announce Jay Crowley, Vice President of Unique Device Identification Services and Solutions, will discuss FDA UDI regulations at the UDI Conference on October 29, 2014.
UDI Compliance Meets UDI Use - The Future of UDI in the Healthcare System
Wednesday, October 29 at 9:00 a.m.
The Reality of UDI Implementation
Wednesday, October 29 at 3:00 p.m.
The UDI Conference is an opportunity to receive guidance and training on the UDI Regulation, hear from UDI compliance experts and learn about the benefits of a UDI system.
“I continue to enjoy working with companies to address the challenges of UDI implementation,” said Crowley. “All of us at USDM are looking forward to working with stakeholders to help their organizations implement UDI in a way that helps them realize all the benefits of UDI.”
As Vice President of UDI Services and Solutions at USDM Life Sciences, Crowley helps medical device manufacturers achieve regulatory compliance as well as internal benefits and competitive advantage with UDI implementation.
Crowley held various positions over nearly 27 years at FDA. Most recently, he was Senior Advisor for Patient Safety, in FDA’s Center for Devices and Radiological Health. Crowley had primary responsibility for the development and implementation of FDA’s Unique Device Identification System.
The USDM Life Sciences UDI team will be available to discuss their services and the USDM UDI Connect App at booth #19 during the conference. The UDI Conference is at the Hilton Baltimore in Baltimore, MD October 28-29, 2014.
About USDM Life Sciences:
USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries. USDM Life Sciences has more than 14 years of experience supplying our clients in the life science industry with compliance services during each phase of their drug and product development cycle while partnering with best of breed organizations to help companies simplify, unify and optimize their business and compliance objectives. For more information, please visit http://www.usdm.com.